期刊文献+

COX-2、nm23和C-erbB-2在乳腺癌组织中的表达及其临床意义 被引量:8

Expressions of COX-2,Nm23 and C-erbB-2 in the Breast Cancer Tissues
暂未订购
导出
摘要 目的探讨COX-2、nm23和C-erb B-2在乳腺癌组织中的表达及其临床意义。方法采用免疫组化法及荧光免疫杂交法检测正常乳腺、乳腺良性疾病和乳腺癌组织中COX-2、nm23及C-erb B-2的表达情况。结果乳腺癌组织中COX-2和C-erb B-2的表达明显高于正常乳腺组织及乳腺良性疾病组织,nm23的表达低于正常乳腺组织及乳腺良性疾病组织(P<0.05)。COX-2和C-erb B-2的表达与乳腺癌患者TNM分期、淋巴结转移有关(P<0.05);nm23表达与乳腺癌患者TNM分期、组织学分级及淋巴结转移有关(P<0.05)。乳腺癌组织中,COX-2与C-erb B-2表达呈显著正相关(r=0.78,P<0.05),nm23与COX-2、C-erb B-2表达呈显著负相关(r=-0.87、-0.93,P<0.05)。结论乳腺癌组织中COX-2和C-erb B-2的高表达、nm23的低表达与乳腺癌的疾病进展关系密切,三者联合检测有利于乳腺癌的生物学行为和预后判断。 Objective To explore the expressions of COX-2,nm23 and C-erbB-2 in the breast cancer tissues and their clinical significance. Methods Immunohistochemical method and fluorescence hybridization assay were used to detect the expressions of COX-2,nm23 and C-erbB-2 in the normal breast tissues,breast benign disease tissues and breast cancer tissues. Results The expressions of COX-2 and C-erbB-2 in the breast cancer tissues were significantly higher than those in the normal breast tissues and the benign breast disease tissues(P〈0. 05);while the expression of nm23 in the breast cancer tissues was lower than those in the normal breast tissues and the benign breast disease tissues(P〈0. 05). The expressions of COX-2 and C-erbB-2 in the breast cancer were positively correlated with TNM stage and lymphnode metastasis(P〈0. 05);while the expression of nm23 in the breast cancer was negatively correlated with TNM stage,histological grade and lymphnode metastasis(P〈0. 05). There was significantly positive correlation between the expressions of COX-2 and C-erbB-2 in the breast cancer tissues( r =0. 78,P〈0. 05);while the expression of nm23 was negativly correlated with the expressions of COX-2 and C-erbB-2(r= -0. 87,-0. 93;P〈0. 05). Conclusion The high expressions of COX-2 and C-erbB-2 and the low ex-pression of nm23 in the breast cancer tissues are closely related with the progression of breast cancer,the combined detection of these three markers couldindicate the biological behaviour and prognosis of breast cancer.
出处 《肿瘤基础与临床》 2015年第2期99-102,共4页 journal of basic and clinical oncology
关键词 乳腺癌 COX-2 NM23 C-ERB B-2 免疫组化 breast cancer immunohistochemistry
  • 相关文献

参考文献11

  • 1孙强.乳腺癌的早期诊断[J].实用医学杂志,2007,23(1):1-3. 被引量:77
  • 2Da MX,Wu XT,Wang J,et al. Expression of cyclooxygenase-2 and vascular endothelial growth factor-C correlates with lymphangiogen- esisand lymphatic invasion in human gastric cancer[ J]. Arch Med Res,2008,39( 1 ) :92 -99.
  • 3Scuderi MR ,Anfuso CD ,Lupo G,et al. Expression of Ca(2 + )-in- dependent and Ca(2 + ) -dependent phospholipases A (2) and cy- clooxygenases in humanmelanocytes and malignant melanoma cell lines[ J]. Biochim Biophys Acta,2008,1781 (10) :635 - 642.
  • 4Watanabe O,Shimizu T, Imamura H, et al. Expression of cyclooxy- genase-2 in malignant and benign breast tumors [ J ]. Anticancer Res ,2003,23 (4) :3215 - 3221.
  • 5Spizzo G,Gastl G,Wolf D,et al. Correlation of COX-2 and Ep-CAM overexpression in human invasive breast cancer and its impact on survival [ J ]. Br J Cancer,2003,88 (4) :574 - 578.
  • 6Singh-Ranger G, Kirkpatrick KL, Clark GM, et al. Cyclo-oxygenase- 2 (COX-2) mRNA expression correlates with progesterone receptor positivity in human breast cancer[ J]. Curt Med Res Opin,2003,19 (2) :131 -134.
  • 7Hennessy C, Henry JA, May FE, et al. Expression of the antimcta- static gene nm23 in human breast cancer: an association with good prognosis[ J]. J Natl Cancer Inst, 1991,83 (4) :281 - 285.
  • 8闵大六,徐晓丽,孙孟红,施达仁.乳腺癌组织中uPA、uPAR及nm23-H1的表达[J].临床与实验病理学杂志,2003,19(3):249-251. 被引量:3
  • 9Carraway KL 3rd, Weber JL, Unger M J, et al. Neuregulin-2, a new ligand of ErbB3/ErbB4-receptor tyrosine kinases [ J ]. Nature, 1997,387(6632) :512 -516.
  • 10Linderholm B, Andersson J, Lindh B, et al. Overexpression of C- erbB-2 is related to a higher expression of vascular endothelial growth factor (VEGF) and constitutes an independent prognostic factor in primary node-positive breast cancer after adjuvant systemic treatment[ Jl. Eur J Cancer,2004,40( 1 ) :33 -42.

二级参考文献16

  • 1[1]Blasi F. Urokinase and urokinase receptor: a paracrine/autocrine system regulating cell migration and invasiveness. Bio Essays, 1993,15:105.
  • 2[2]Migtatti P, Rifkin DB. Biology and biochemistry of proteinase in tumor invasion. Physiol Review, 1993,73(1):161~95.
  • 3[3]Steeg PS, Bevilacqua G, Kopper L,et al. Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst, 1988,80:200~4.
  • 4[4]Vecchio SD,Stoppelli MP,Carrieo MV,et al. Human urokinase receptor concentration in malignant and benign breast tumors by in vitro quantitative autoradiography: comparison with urokinase levels. Cancer Res, 1993,53:3198~206.
  • 5[5]Carriero MV,Franco P,Del VS, et al. Tissue distribution of soluble and receptor bound urokinase in human breast cancer using a panel of monoclonal antibodies. Cancer Res, 1994,54:5445.
  • 6Dahiya R, Deng G. Molecular prognostic markers in breast cancer. Breast Cancer Res &amp;Treat,1998;52(1-3):185.
  • 7Slamon DJ, Clark GM, Wong SG, et al. Human breast cancer: Correlation of relapse and survivalwith amplification of the HER-2/neu oncogene.Science,1987;235(4785):177.
  • 8Kallioniemi OP. Association of C-erbB2 protein overexpression with high rate of cell proliferation, increased risk of visceral metastasis and poor longterm survival in breast cancer. Int J Cancer,1991;49(5):650.
  • 9Tsutsui S, Ohno S, Murakami S, et al. Prognostic value of C-erbB2 expression in breast cancer. J Surg Oncol,2002;79(4):216.
  • 10Ring AE, Ellis PA. Predictors of response to systemic therapy in breast cancer. Forum,2002;12(1):19.

共引文献114

同被引文献63

引证文献8

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部